DIR Return Create A Forum - Home
---------------------------------------------------------
MS Speaks
HTML https://msspeaks.createaforum.com
---------------------------------------------------------
*****************************************************
DIR Return to: TYSABRI (natalizumab)
*****************************************************
#Post#: 3726--------------------------------------------------
Tysabri biosimilar for relapsing MS under FDA review
By: agate Date: July 28, 2022, 12:12 am
---------------------------------------------------------
A biosimilar isn't quite a bioequivalent but biosimilars of many
costly drugs are being developed because they're apparently
close enough to be safe--and are far less expensive. Now Tysabri
may become available in the US in biosimilar form (natalizumab).
From Multiple Sclerosis News Today (July 27,
2022)--"Natalizumab, biosimilar of Tysabri for relapsing MS,
under FDA review":
HTML https://multiplesclerosisnewstoday.com/news-posts/2022/07/27/natalizumab-relapsing-ms-tysabri-biosimilar-fda-review/
#Post#: 4136--------------------------------------------------
Tyruko (Tysabri biosimilar) has FDA approval (FDA news release)
By: agate Date: August 26, 2023, 7:39 pm
---------------------------------------------------------
FDA news release (August 24, 2023)--"FDA Approves First
Biosimilar to Treat Multiple Sclerosis":
HTML https://www.fda.gov/news-events/press-announcements/fda-approves-first-biosimilar-treat-multiple-sclerosis
#Post#: 4140--------------------------------------------------
FDA approves Tyruko, natalizumab (Tysabri) biosimilar
By: agate Date: August 31, 2023, 1:19 am
---------------------------------------------------------
Another news story about Tyruko--from Medical News Today (August
30, 2023)--"FDA Approves First Natalizumab Biosimilar for MS
Treatment":
HTML https://tinyurl.com/2p8rcarh
*****************************************************